GLPBio

Ubiquitination/ Proteasome

Research Areas

Products Related to Ubiquitination/ Proteasome(1361)

  • GC52447 structure
    GC52447Suc-Leu-Leu-Val-Tyr-AMC (trifluoroacetate salt)
    Purity: >98.00%

    A fluorogenic substrate for the 20S proteasome and calpains

  • GC52477 structure
    GC52477Corynoxine (hydrochloride)
    Purity: >98.00%

    An indole alkaloid

  • GC60076 structure
    GC60076Bigelovin
    CAS: 3668-14-2
    Purity: >99.50%

    Bigelovin, a sesquiterpene lactone isolated from Inula helianthus-aquatica, is a selective retinoid X receptor α agonist. Bigelovin suppresses tumor growth through inducing apoptosis and autophagy via the inhibition of mTOR pathway regulated by ROS generation.

  • GC60159 structure
    GC60159Ezetimibe ketone
    CAS: 191330-56-0
    Purity: >98%

    Ezetimibe ketone (EZM-K) is a phase-I metabolite of Ezetimibe.

  • GC60241 structure
    GC60241Melatonin D5
    CAS: 66521-38-8
    Purity: >98%

    An internal standard for the quantification of melatonin

  • GC60257 structure
    GC60257MSC1094308
    CAS: 2219320-08-6
    Purity: >98.00%

    MSC1094308 is a non-competitive and reversible VPS4B/p97 (VCP) (I/II type AAA ATPase) allosteric inhibitor, with IC50 values of 0.71 μM and 7.2 μM for VPS4B and p97, respectively. MSC1094308 inhibits the D2 ATPase activity by binding to a drugable hotspot of p97. MSC1094308 can be used in study of cancer.

  • GC60325 structure
    GC60325Rilmenidine
    CAS: 54187-04-1
    Purity: >98%

    An antihypertensive agent

  • GC60395 structure
    GC60395(3S,5R)-Fluvastatin D6
    CAS: 2249799-34-4
    Purity: >98%

    (3S,5R)-Fluvastatin D6 is the deuterium labeled (3S,5R)-Fluvastatin sodium.

  • GC60567 structure
    GC60567Afatinib impurity 11
    CAS: 1402086-20-7
    Purity: >99.00%

    Afatinib impurity 11 is an impurity of Afatinib. Afatinib is an irreversible EGFR family inhibitor with IC50s of 0.5 nM, 0.4 nM, 10 nM and 14 nM for EGFRwt, EGFRL858R, EGFRL858R/T790M and HER2, respectively.

  • GC60668 structure
    GC60668Calcimycin hemimagnesium
    CAS: 72124-77-7
    Purity: >98%

    Calcimycin (A-23187) hemimagnesium is an antibiotic and a unique divalent cation ionophore (like calcium and magnesium).

  • GC60688 structure
    GC60688Cereblon modulator 1
    CAS: 1860875-51-9
    Purity: >99.50%

    Cereblon modulator 1 (CC-90009) is a first-in-class GSPT1-selective cereblon (CRBN) E3 ligase modulator, acts as a molecular glue.

  • GC60700 structure
    GC60700Chloroquine D5
    CAS: 1854126-41-2
    Purity: >98%

    Chloroquine D5 is deuterium labeled Chloroquine.

  • GC60826 structure
    GC60826Etoposide phosphate
    CAS: 117091-64-2
    Purity: >96.00%

    Etoposide phosphate (BMY-40481) is a potent anti-cancer chemotherapy agent and a selective topoisomerase II inhibitor?to prevent re-ligation of DNA strands.

  • GC60868 structure
    GC60868Gefitinib D8
    CAS: 857091-32-8
    Purity: >98.00%

    Gefitinib D8 (ZD1839 D8) is a deuterium labeled Gefitinib. Gefitinib is an EGFR tyrosine kinase inhibitor, with IC50 of 2-37 nM in NR6wtEGFR cells.

  • GC60882 structure
    GC60882Glyphosate
    CAS: 1071-83-6
    Purity: ≥99.00%

    An herbicide

  • GC60891 structure
    GC60891GW406108X
    CAS: 1644443-92-4
    Purity: >98.00%

    GW406108X is a specific Kif15 (Kinesin-12) inhibitor with an IC50 of 0.82 uM in ATPase assays. GW406108X, a potent autophagy inhibitor, shows ATP competitive inhibition against ULK1 with a pIC50 of 6.37 (427 nM). GW406108X inhibits ULK1 kinase activity and blocks autophagic flux, without affecting the upstream signaling kinases mTORC1 and AMPK.

  • GC60930 structure
    GC60930Imatinib D4
    CAS: 1134803-16-9
    Purity: >98%

    Imatinib D4 (STI571 D4) is a deuterium labeled Imatinib (STI571). Imatinib is an orally bioavailable tyrosine kinases inhibitor that selectively inhibits BCR/ABL, v-Abl, PDGFR and c-kit kinase activity.

  • GC60935 structure
    GC60935Indomethacin sodium hydrate
    CAS: 74252-25-8
    Purity: >98.00%

    Indomethacin (Indometacin) sodium hydrateis a potent, orally active COX1/2 inhibitor with IC50 values of 18 nM and 26 nM for COX-1 and COX-2, respectively.

  • GC61003 structure
    GC61003Loperamide D6 hydrochloride
    CAS: 1189469-46-2
    Purity: >98%

    Loperamide D6 hydrochloride (R-18553 D6 hydrochloride) is a deuterium labeled Loperamide hydrochloride.

  • GC61045 structure
    GC61045Metformin D6 hydrochloride
    CAS: 1185166-01-1
    Purity: >98.00%

    An internal standard for the quantification of metformin

  • GC61093 structure
    GC61093MSAB
    CAS: 173436-66-3
    Purity: >99.00%

    MSAB (methyl 3-{[(4-methylphenyl)sulfonyl]amino}benzoate) is a selective Wnt/β-catenin signaling inhibitor binding to β-catenin and promoting its degradation with an EC 50 of 0.583μM.

  • GC61155 structure
    GC61155Omeprazole sodium
    CAS: 95510-70-6
    Purity: >98.00%

    Omeprazole sodium (H 16868 sodium), a proton pump inhibitor (PPI), is available for treatment of acid-related gastrointestinal disorders.

  • GC61183 structure
    GC61183Physalin B
    CAS: 23133-56-4
    Purity: >98%

    Physalin B, one of the major active steroidal constituents of Cape gooseberry, induces cell cycle arrest and triggers apoptosis in breast cancer cells through modulating p53-dependent apoptotic pathway. Physalin B inhibits the ubiquitin-proteasome pathway and induces incomplete autophagic response in human colon cancer cells in vitro.

  • GC61221 structure
    GC61221PTP1B-IN-9
    CAS: 145888-79-5
    Purity: >98.00%

    PTP1B-IN-9 is a ubiquitin-proteasome system (UPS)-stressor. PTP1B-IN-9 inhibits ubiquitin-mediated protein degradation upstream of the 20S proteasomal catalytic activites. PTP1B-IN-9 triggers a ubiquitin-proteasome-system (UPS)-stress response without affecting 20S proteasome catalytic activities. Anticancer activity.